News

Mar 26 2018

Business Insider featured Auris’s Monarch Platform, including an animation of what happens during a bronchoscopy procedure. The article also notes that the Monarch Platform integrates the latest advancements in robotics, software, data science, and endoscope innovation, saying “Auris’s newest platform, called Monarch, is designed with the intent of transforming endoscopy, particularly in the field of lung cancer diagnosis.”

Mar 25 2018

Auris is featured in this TechCrunch article, titled “Monarch is a new platform from surgical robot pioneer Frederic Moll,” for the reveal of its robotic endoscopic technology called the Monarch Platform. With the use of the Monarch Platform’s flexible robotics and controller, a physician can navigate to hard-to-reach places in the periphery of the lung. Auris’s goal is to help clinicians diagnose and treat lung cancer in the early stages, because the prognosis for lung cancer is worse for the patient if it is discovered at an advanced stage.

Mar 23 2018

Auris Health's Monarch Platform has been cleared by the FDA. The company's Chief Strategy Officer, Josh DeFonzo, summarizes some of the key features and benefits of the new technology, aimed to improve the current bronchoscopy procedure.

Mar 23 2018

Fred Moll’s Auris Health has been granted FDA clearance for its surgical robotics platform. The nod clears the Intuitive Surgical founder’s latest venture to sell the device for use in bronchoscopic diagnostic and therapeutic procedures in lung cancer patients.

Mar 23 2018

Operated by a hand-held controller, Auris Health’s recently FDA-cleared Monarch Platform has lung cancer as its first targeted disease state. According to the article, the FDA determined the technology Auris built was equivalent to other bronchoscopic procedures that use endoscopy to examine a patient’s lungs. However, with the integration of the latest advancements in robotics, software, data science, and endoscope innovation, Auris aims to go further than conventional endoscopy.

Jan 19 2018

Auris Health, formerly known as Auris Surgical Robotics, made its way to the top for most venture capital funding in the medical device industry in 2017, marking an exciting time not only for Auris but for the industry overall last year.

Jan 10 2018

Auris Health, formerly known as Auris Surgical Robotics, finds itself in good company with other billion-dollar valuation startups, all working to revolutionize healthcare in 2018.

Nov 16 2017

Even when Auris Health, Inc., formerly known as Auris Surgical Robotics, was in stealth mode, it was featured as one of the new surgical robots about to enter the surgical suites. Dr. Fred Moll, CEO of Auris, is a well known as a pioneer in medical robotics. When Dr. Moll began developing the Monarch Platform, there was much speculation about his work. Lung cancer was identified as a key disease state that Auris was going to tackle.

Oct 27 2017

In this video interview at CHEST's Annual Meeting, Dr. Machuzak of the Cleveland Clinic summarizes his experience using the Monarch Platform in Auris's study, REACH Assessment: Advanced Bronchoscopic Techniques. According to Machuzak, Auris's robotic bronchoscope was compared to other standard flexible bronchoscopes, and the results were encouraging.

Aug 07 2017

Auris Health, formerly known as Auris Surgical Robotics, is featured in the article for raising an unprecedented amount of funding in 2017. According to this article, Auris raised $280 million in a Series D round. After raising a large investment, Auris has remained silent about its work on the Monarch Platform, creating great intrigue in the financial media.